Mannix Pharma (Opc) Private Limited

Founded in 2018 and headquartered in Delhi, India.

2018 | Delhi (India) | Active
Last Updated: January 12, 2025

Mannix Pharma (Opc) Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 50.00 K
  • Company Age 6 Year, 8 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth 109.74%
  • Profit Growth 12.48%
  • Ebitda 3.10%
  • Net Worth 7.08%
  • Total Assets 7.08%

About Mannix Pharma (Opc)

Mannix Pharma (Opc) Private Limited (MPOPL) is a Company incorporated in India on 12 June 2018 (Six years and eight months 14 days old ). Its registered office is in Delhi, India.

The Company is engaged in the Business Services Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.

Shivani Varthval serves as a director at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74999DL2018OPC335193

  • Company No.

    335193

  • Incorporation Date

    12 Jun 2018

  • Date of AGM

    -

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Business Services

Who are the key members and board of directors at Mannix Pharma (Opc)?

Board Members (1)

NameDesignationAppointment DateStatus
Shivani Varthval Country flag representing In Director 12-Jun-2018Current

Financial Performance of Mannix Pharma (Opc).

Mannix Pharma (Opc) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 109.74% increase. The company also saw a substantial improvement in profitability, with a 12.48% increase in profit. The company's net worth moved up by a moderate rise of 7.08%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
109.74%
Revenue from Operations
109.74%
Total Assets
7.08%
Profit or Loss
12.48%
Net Worth
7.08%
EBITDA
3.10%

What is the Ownership and Shareholding Structure of Mannix Pharma (Opc)?

Unlock access to Mannix Pharma (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Mannix Pharma (Opc)?

Unlock and access historical data on people associated with Mannix Pharma (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mannix Pharma (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mannix Pharma (Opc)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Mannix Pharma (Opc)

Recent activity within the organization

  • Balance Sheet

    Mannix Pharma (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.

    31 Mar 2022

  • Director Appointment

    Shivani Varthval was appointed as a Director was appointed as a Director on 12 Jun 2018 & has been associated with this company since 6 years 8 months .

    12 Jun 2018

  • Company Incorporation

    Mannix Pharma (Opc) Private Limited was registered on 12 Jun 2018 with Roc Delhi & aged 6 years 8 months as per MCA records.

    12 Jun 2018

Frequently asked questions

  • Mannix Pharma (Opc) Private Limited was incorporated on 12 Jun 2018.

  • The authorized share capital of Mannix Pharma (Opc) Private Limited is ₹ 0.50 M and paid-up capital is ₹ 50.00 K .

  • Currently 1 director is associated with Mannix Pharma (Opc) Private Limited.

    • Shivani Varthval
  • As per Ministry of Corporate Affairs (Mca), the registered address of Mannix Pharma (Opc) Private Limited is Space No-303 At P.No-20 Shivam Tower Complex Paschim Vihar India, New Delhi, 110063.

  • The corporate identification number (CIN) of Mannix Pharma (Opc) Private Limited is U74999DL2018OPC335193 and the company number is 335193 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2022, the revenue trend for Mannix Pharma (Opc) Private Limited has risen by 109.74%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Mannix Pharma (Opc) Private Limited has experienced an upsurge of 7.08%.

  • The most recent Balance Sheet for Mannix Pharma (Opc) Private Limited was filed with the ROC on 31 Mar 2022.

People also Viewed

Similar Companies Based on Miscellaneous Business Activities